The company began by using AI to turn terabytes of information into 150-word synopses of patient histories, updated every two ...

R&D Expenses: Research and development expenses for the third quarter of 2024 were $1.0 million, compared to $1.9 million for the third quarter of 2023. Additionally, the Company recorded a $9.7 ...

These "never words" can be harmful when spoken by clinicians to patients and families facing serious illness. Seriously ill patients and their families experience intense emotional suffering, and ...